Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer

Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer

Bibliographic Details
Main Authors: T Brown, A Boland, A Bagust, J Oyee, J Hockenhull, Y Dundar, R Dickson, VS Ramani, C Proudlove
Format: Article
Language:English
Published: NIHR Journals Library 2010-10-01
Series:Health Technology Assessment
Online Access:https://doi.org/10.3310/hta14suppl2/10
id doaj-4be871c811b642278051ac0af45a8f91
record_format Article
spelling doaj-4be871c811b642278051ac0af45a8f912020-11-24T21:11:47ZengNIHR Journals LibraryHealth Technology Assessment1366-52782010-10-0114Suppl. 210.3310/hta14suppl2/10Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancerT Brown0A BolandA BagustJ OyeeJ HockenhullY DundarR DicksonVS RamaniC ProudloveLiverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UKhttps://doi.org/10.3310/hta14suppl2/10
collection DOAJ
language English
format Article
sources DOAJ
author T Brown
A Boland
A Bagust
J Oyee
J Hockenhull
Y Dundar
R Dickson
VS Ramani
C Proudlove
spellingShingle T Brown
A Boland
A Bagust
J Oyee
J Hockenhull
Y Dundar
R Dickson
VS Ramani
C Proudlove
Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
Health Technology Assessment
author_facet T Brown
A Boland
A Bagust
J Oyee
J Hockenhull
Y Dundar
R Dickson
VS Ramani
C Proudlove
author_sort T Brown
title Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
title_short Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
title_full Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
title_fullStr Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
title_full_unstemmed Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
title_sort gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
publisher NIHR Journals Library
series Health Technology Assessment
issn 1366-5278
publishDate 2010-10-01
url https://doi.org/10.3310/hta14suppl2/10
work_keys_str_mv AT tbrown gefitinibforthefirstlinetreatmentoflocallyadvancedormetastaticnonsmallcelllungcancer
AT aboland gefitinibforthefirstlinetreatmentoflocallyadvancedormetastaticnonsmallcelllungcancer
AT abagust gefitinibforthefirstlinetreatmentoflocallyadvancedormetastaticnonsmallcelllungcancer
AT joyee gefitinibforthefirstlinetreatmentoflocallyadvancedormetastaticnonsmallcelllungcancer
AT jhockenhull gefitinibforthefirstlinetreatmentoflocallyadvancedormetastaticnonsmallcelllungcancer
AT ydundar gefitinibforthefirstlinetreatmentoflocallyadvancedormetastaticnonsmallcelllungcancer
AT rdickson gefitinibforthefirstlinetreatmentoflocallyadvancedormetastaticnonsmallcelllungcancer
AT vsramani gefitinibforthefirstlinetreatmentoflocallyadvancedormetastaticnonsmallcelllungcancer
AT cproudlove gefitinibforthefirstlinetreatmentoflocallyadvancedormetastaticnonsmallcelllungcancer
_version_ 1716752710791856128

Similar Items